MAT2203
MB-70007
Phase 3 small_molecule active
Quick answer
MAT2203 for Cryptococcal Meningitis is a Phase 3 program (small_molecule) at Matinas BioPharma Holdings with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Matinas BioPharma Holdings
- Indication
- Cryptococcal Meningitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active